Title: Horley NJ, et al. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines. Eur J Med Chem. 2017 Mar 31;129:159-174.
908563-68-8
64908-88-9
315681-44-8
1254472-97-3 | PBI-4050 sodium salt | AA01EOJT | MFCD31657323
1039455-84-9 | COTI-2 | AA01EONR | MFCD28502211
1823274-68-5 | 1-(1,3-benzodioxol-5-yl)-2-[(phenylmethyl)amino]-1-propanone,monohydrochloride | AA01EOX2 | MFCD27966832
1569257-94-8 | 2,2,6,6-tetramethyl-4-[[2-(triphenylphosphonio)acetyl]amino]-1-piperidinyloxy,monochloride,monohydrate | AA01EP6H
18268-14-9 | 2-[(1-methylethyl)amino]-1-phenyl-1-pentanone,monohydrochloride | AA01EPFC
925448-37-9 | 3-oxo-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-hexadecanamide | AA01EPKX | MFCD31010424
338773-13-0 | 1-(4-chlorophenyl)-4-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline | AA01EPR9 | MFCD00974644
67492-17-5 | N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-nonadecanamide | AA01EPYC
14015-55-5 | octadecanoicacid,3-hydroxy-2-[(1-oxohexadecyl)oxy]propylester | AA01EQ7B | MFCD11974111
2098563-70-1 | FluorescentprobeQG-1 | AA01EQD2